We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-0.6%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$280M
AUM Growth
-$12.6M
Cap. Flow
-$11.9M
Cap. Flow %
-4.24%
Top 10 Hldgs %
55.57%
Holding
53
New
13
Increased
14
Reduced
5
Closed
20

Top Buys

Rank Stock Value
1
AEGR
Aegerion Pharmaceuticals
AEGR
+$14.5M
2
ENR icon
Energizer
ENR
+$11.5M
3
HAIN icon
Hain Celestial
HAIN
+$10.2M
4
VNDA icon
Vanda Pharmaceuticals
VNDA
+$8.68M
5
THC icon
Tenet Healthcare
THC
+$8.27M

Top Sells

Rank Stock Value
1
PTX
Pernix Therapeutics Holdings, Inc.
PTX
+$15.2M
2
XNPT
XENOPORT, INC.
XNPT
+$12.6M
3
KODK icon
Kodak
KODK
+$12.6M
4
BDBD
BOULDER BRANDS INC
BDBD
+$10.4M
5
PBY
PEP BOYS MANNY MOE& JACK
PBY
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 45.72%
2 Consumer Discretionary 14.08%
3 Consumer Staples 8.36%
4 Industrials 6.68%
5 Financials 2.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$782B
$40.8M 14.55%
200,000
+100,000
+100% +$20.5M
ATRS
2
DELISTED
Antares Pharma, Inc.
ATRS
$16M 5.72%
13,240,000
+4,940,000
+60% +$6.87M
VNDA icon
3
Vanda Pharmaceuticals
VNDA
$327M
$15.2M 5.41%
1,630,000
+870,000
+114% +$8.68M
FRPT icon
4
Freshpet
FRPT
$2.78B
$14.4M 5.13%
1,694,000
+574,000
+51% +$4.99M
RXDX
5
DELISTED
Ignyta, Inc.
RXDX
$12.8M 4.55%
952,000
+18,000
+2% +$217K
BDSI
6
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$12.6M 4.48%
2,620,000
+1,140,000
+77% +$6.46M
INVA icon
7
Innoviva
INVA
$1.6B
$12.3M 4.39%
750,000
-591,000
-44% -$5.43M
AEGR
8
DELISTED
Aegerion Pharmaceuticals
AEGR
$12.1M 4.33%
+1,202,000
New +$14.5M
ENR icon
9
Energizer
ENR
$1.39B
$10.2M 3.65%
+300,000
New +$11.5M
ACOR
10
DELISTED
Acorda Therapeutics
ACOR
$9.41M 3.36%
1,833
-1,650
-47% -$7.21M
TVTY
11
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$9.27M 3.31%
720,000
+18,000
+3% +$219K
JCP
12
DELISTED
J.C. Penney Company, Inc.
JCP
$9.06M 3.23%
1,360,000
+620,000
+84% +$5.17M
HAIN icon
13
Hain Celestial
HAIN
$50.6M
$9.05M 3.23%
+224,000
New +$10.2M
SPNC
14
DELISTED
Spectranetics Corp
SPNC
$8.82M 3.15%
586,000
-38,000
-6% -$502K
AVTA
15
DELISTED
Avantax, Inc. Common Stock
AVTA
$8.17M 2.92%
834,000
+54,000
+7% +$596K
FL
16
DELISTED
Foot Locker
FL
$8.07M 2.88%
+124,000
New +$8.24M
DECK icon
17
Deckers Outdoor
DECK
$14.8B
$7.74M 2.76%
984,000
+264,000
+37% +$2.34M
THC icon
18
Tenet Healthcare
THC
$16.8B
$7.64M 2.72%
+252,000
New +$8.27M
EXEL icon
19
Exelixis
EXEL
$14.1B
$7.16M 2.56%
+1,270,000
New +$7.11M
LEAF
20
DELISTED
Leaf Group Ltd.
LEAF
$6.36M 2.27%
1,156,000
+62,000
+6% +$322K
KATE
21
DELISTED
Kate Spade & Company
KATE
$6.04M 2.16%
+340,000
New +$6.64M
XNPT
22
DELISTED
XENOPORT, INC.
XNPT
$5.93M 2.12%
1,080,000
-2,250,000
-68% -$12.6M
VSTO
23
DELISTED
Vista Outdoor Inc.
VSTO
$4.72M 1.68%
+106,000
New +$4.65M
GNC
24
DELISTED
GNC Holdings, Inc.
GNC
$3.78M 1.35%
+122,000
New +$4.11M
ARCO icon
25
Arcos Dorados Holdings
ARCO
$1.73B
$3.67M 1.31%
1,212,832
-226,122
-16% -$684K
1
2 3

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q4 2015 Portfolio in Review

As of Q4 2015, Armistice Capital held 53 positions worth $280M, down 4.3% from $293M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital withdrew a net $11.9M in Q4 2015, closing 20 positions and reducing 5 holdings. Its most notable exit was Pernix Therapeutics Holdings, Inc., an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Armistice Capital opened a new position in Aegerion Pharmaceuticals worth $12.1M.

  • Armistice Capital's largest Q4 2015 buy was Aegerion Pharmaceuticals: 1,202,000 shares worth $12.1M.
  • Armistice Capital added most to Vanda Pharmaceuticals in Q4 2015, an estimated $8.68M increase.
  • Armistice Capital's biggest Q4 2015 reduction was XENOPORT, INC., cutting an estimated $12.6M.
  • Armistice Capital fully exited Pernix Therapeutics Holdings, Inc. in Q4 2015, selling an estimated $15.2M.
  • Armistice Capital's ten largest holdings make up 56% of its $280M portfolio in Q4 2015.
  • Armistice Capital opened 13 new positions and closed 20 in Q4 2015.
  • Armistice Capital's portfolio value fell 4.3% quarter-over-quarter to $280M.

Based on Armistice Capital's 13F filing for Q4 2015, filed 16 Feb 2016.